Evidence map›Paper›PMID 33281736›Full record

ArticleFrontiers in neurology2020

Normobaric Oxygen May Ameliorate Cerebral Venous Outflow Disturbance-Related Neurological Symptoms.

Jiayue Ding, Yu Liu, Xiangyu Li, Zhiying Chen, Jingwei Guan, Kexin Jin, Zhongao Wang, Yuchuan Ding, Xunming Ji, Ran Meng

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Frontiers in neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03373292 (Evaluation of the Feasibility, Safety and Efficacy of Venous Stenting for Internal Jugular Vein Stenosis), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03373292 phase1unknown statusnot on this map

Evaluation of the Feasibility, Safety and Efficacy of Venous Stenting for Internal Jugular Vein Stenosis

TypeinterventionalSponsorCapital Medical UniversityRan2018 to 2020Enrolled60ConditionsStent Stenosis, Intracranial Hypertension, Headache, TinnitusArmsVenous stenting for internal jugular vein stenosis, One-month routine medical treatment followed by venous stenting for internal jugular vein stenosis
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Normobaric Hyperoxia Therapy in Treating Stroke.Clinical interventions in aging · 2025
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Jiayue DingDepartment of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
Yu LiuEpilepsy Center, Beijing Fengtai You'anmen Hospital, Beijing, China.
Xiangyu LiDepartment of Neurology, Tianjin Huanhu Hospital, Tianjin, China.
Zhiying ChenDepartment of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
Jingwei GuanDepartment of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
Kexin JinDepartment of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
Zhongao WangDepartment of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
Yuchuan DingDepartment of China-America Institute of Neuroscience, Xuanwu Hospital, Capital Medical University, Beijing, China.
Xunming JiAdvanced Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China.
Ran MengDepartment of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
Capital Medical University · CNBeijing Fengtai Hospital · CNChinese Institute for Brain Research · CNTianjin Huanhu Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cerebral venous outflow disturbance (CVOD) has begun to garner the attention of researches owing to a series of clinical symptoms that impose a significant impact on people's quality of life. Herein, we aimed to investigate whether normobaric oxygen (NBO) can ameliorate CVOD-induced neurological symptoms. This was one part of the prospective trial registered in ClinicalTrials.gov (NCT03373292). A total of 37 CVOD patients were divided into the NBO group (5-8 L/min of oxygen inhalation, 1 h per time, 3 times daily,

Indexed as

brain dysfunctioncerebral venous outflow disturbanceEEGneurological impairmentnormobaric oxygen

Identifiers

PMID33281736
PMCPMC7691288
OpenAlexW3101891520

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.